Dr. Howard Levy, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 65 Van Dyke Rd, Hopewell, NJ 08525 Phone: 609-466-3785 Fax: 609-466-3785 |
News Archive
Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.
A new study from Bournemouth University has investigated how to increase protein intake in older people living in the community.
A 21-year old Airman severely wounded in Afghanistan is recovering at Walter Reed Army Medical Center after several surgeries and an unprecedented transplant.
Michael Croft, Ph.D., a researcher at the La Jolla Institute for Allergy & Immunology, has discovered a molecule's previously unknown role as a major trigger for airway remodeling, which impairs lung function, making the molecule a promising therapeutic target for chronic asthma, chronic obstructive pulmonary disease and several other lung conditions.
› Verified 1 days ago